Synchrogenix, Certara’s Regulatory Writing Consultancy, and CISCRP Partner to Help Biopharm Companies Meet Clinical Data Transparency Requirements

Business News
Print
PRINCETON, N.J.--(BUSINESS WIRE)--Certara® and CISCRP today announced that they are partnering to produce high-quality lay summaries of clinical trials for pharmaceutical companies to share with the general public.

imageimage
image

Read more